newli
identifi
coronaviru
pose
signific
threat
public
health
sinc
decemb
host
cell
receptor
sever
acut
respiratori
syndrom
coronaviru
sar
recent
demonstr
mediat
infect
interestingli
besid
respiratori
system
substanti
proport
sar
patient
show
sign
variou
degre
liver
damag
mechan
implic
yet
determin
perform
unbias
evalu
cell
type
specif
express
healthi
liver
tissu
use
singl
cell
rnaseq
data
two
independ
cohort
identifi
specif
express
cholangiocyt
result
indic
viru
might
directli
bind
posit
cholangiocyt
necessarili
hepatocyt
find
suggest
liver
abnorm
sar
patient
may
due
hepatocyt
damag
cholangiocyt
dysfunct
caus
drug
induc
system
inflammatori
respons
induc
liver
injuri
find
indic
special
care
liver
dysfunct
instal
treat
patient
hospit
shortli
cure
biorxiv
preprint
rise
liver
enzym
impli
liver
function
damag
patient
infect
merscov
recent
epidemiolog
studi
reveal
initi
patient
infect
variou
degre
liver
function
abnorm
alanin
aminotransferas
alt
aspart
aminotransferas
ast
normal
rang
import
one
decemb
novel
coronaviru
tempor
name
world
health
organ
discov
wuhan
hubei
provinc
china
novel
coronaviru
isol
airway
epitheli
cell
patient
pneumonia
epidemiolog
link
huanan
seafood
market
wuhan
within
month
spread
rapidli
wuhan
provinc
china
countri
around
globe
februari
case
confirm
china
suspect
alarm
number
fatal
unfortun
number
infect
patient
fatal
still
grow
rapidli
effect
drug
clinic
approv
close
relat
sever
acut
respiratori
syndrom
coronaviru
sarscov
propos
share
receptor
angiotensin
convert
enzym
sar
liver
one
largest
organ
bodi
vertebr
locat
portal
system
circul
constantli
expos
dietari
antigen
virus
bacteri
product
inflammatori
potenti
liver
damag
caus
multitudin
factor
exposur
toxin
excess
alcohol
consumpt
bile
duct
prevent
obstruct
viral
infect
hepat
b
viru
hbv
main
caus
viral
agent
hepatocellular
carcinoma
hcc
china
recent
studi
also
found
acut
infect
hepat
e
viru
hev
caus
vari
degre
liver
damag
liver
damag
report
sarsinfect
patient
macrovascularendo
otherendo
tabl
patient
inform
inhous
cohort
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
